Ignite Creation Date:
2025-12-25 @ 12:59 AM
Ignite Modification Date:
2025-12-30 @ 10:46 AM
Study NCT ID:
NCT05230693
Status:
COMPLETED
Last Update Posted:
2025-04-06
First Post:
2022-01-25
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
SPARC Smartphone Application for the Management of Sarcoidosis-Associated Fatigue
Sponsor:
Medical University of South Carolina
Organization:
Study Overview
Official Title:
The SPARC App: A Smartphone Application for the Management of Sarcoidosis-Associated Fatigue
Status:
COMPLETED
Status Verified Date:
2025-03
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
SPARC
Brief Summary:
Fatigue is a pervasive and disabling symptom in sarcoidosis with limited treatment options. There is a significant association between heightened stress and sarcoidosis-associated fatigue. The proposed project will evaluate the usability/feasibility of a smartphone-based stress management application for the self-management of sarcoidosis-associated stress and fatigue.
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
Secondary ID Infos
| Secondary ID | Type | Domain | Link | View |
|---|---|---|---|---|
| 1R21EB025525 | NIH | None | https://reporter.nih.gov/quic… | View |